PROTECTING YOUR RIGHT TO MEDICINES AND MEDICAL DEVICES
Wednesday, 01 April 2020

Vaccine pharmacovigilance is a critical aspect in public health and a key indicator for pharmacovigilance systems. The MCAZ in collaboration with the Expanded Programme on Immunization- Ministry of Health and Child Care (EPI-MoHCC), have continuously worked to develop vaccine pharmacovigilance in Zimbabwe through participation in World Health Organisation (WHO) projects, development and implementation of the Adverse Events Following Immunization (AEFI) surveillance guidelines and conducting trainings for health care professionals on AEFI reporting and case investigations.

To download all forms associated with Vaccine Safety including the WHO Vaccine Safety Fact Sheets click here

Revised AEFI Causality Manual

Brighton Collaboration - Case Definitions

Global Alignment of Immunisation Safety in Pregnancy

Correct Vaccine Temperatures

How to Arrange Vaccines Inside Any Refrigerator

What is Cold Chain Equipment

What Health Workers Must Do to Maintain the Cold Chain

How to Assess Possible Contraindications

Adverse Events Following Immunization Surveillance Guidelines

 

This Site includes links to third party web sites which are not maintained by MCAZ. MCAZ does not review, endorse or approve the third party sites and is not responsible for their content. You agree that linking to or using the third party sites is at your sole risk and that MCAZ will not be liable for any loss or damages arising from your use of those sites. MCAZ will not be responsible for information provided to you on the Other Sites.

Latest News

Draft SADC Variations Guidelines

20 March 2020

Draft SADC Variations Guidelines are now available  Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet

Medicines Information Bulletin - 2019

20 December 2019
Medicines Information Bulletin - 2019

Inside this issue: E-Reporting Tools Safety Notifications for Fluoroquinolones and Quinolones Antibiotics Notification of a potential risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) in patients treated...

Code of Ethics

22 August 2019
Code of Ethics

  In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...

SADC Guideline on Product Information and Labeling

10 July 2019
SADC Guideline on Product Information and Labeling

  Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...

Draft Guidelines For Comments Only: Guideline for Submitting Application for Variations to Registered Medicines

17 May 2019
Draft Guidelines For Comments Only: Guideline for Submitting Application for Variations to Registered Medicines

In line with the WHO guidelines on variations and other SRA guidelines, the EVR Division is updating the MCAZ Guidelines for submitting applications for Variations to Registered Medicines. The update...

Careers @ MCAZ

30 October 2018

The Medicines Control Authority of Zimbabwe (MCAZ) is inviting suitably qualified, honest, self-motivated applicants for the following post: REGULATORY OFFICER x1 POST - LICENSING AND ENFORCEMENT DIVISION Reporting to the...

Fellowship in regulatory science for African Medicine Reviewers/Assessors

26 October 2018
Fellowship in regulatory science for African Medicine Reviewers/Assessors

  Background   The Medicines Control Authority of Zimbabwe (MCAZ) Regional Centre of Regulatory Excellence (ReCORE) in partnership with the European and Developing Countries Clinical Trials Partnership (EDCTP) is offering...

Quality Policy Statement

06 July 2018
Quality Policy Statement

The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...

MCAZ Newsletter

10 May 2018
MCAZ Newsletter

In this issue: MCAZ turns 20 years Basics of reporting Side Effects of medicines Electronic Adverse Drug Reaction Reporting   For more information Please click here to download the Newsletter...

Medicines Information Bulletin - 2018

02 February 2018
Medicines Information Bulletin - 2018

Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download the 2018 Drug Information Bulletin